AP
Alnylam Pharmaceuticals, Inc. - Common Stock
ALNY
Close · 12/11/2026
156.65
1D
-2.00%52-week range
149.18 – 479.79
Volume
35,14,800.00
Price history
ALNY
14/10/2026 to 12/11/2026
O 160.16 H 162.77 L 156.59
1W-0.01%
1M-30.21%
3M-31.49%
6M-46.62%
1Y-65.34%
3Y-7.96%
5Y-15.58%
MAX-17.36%
Fundamentals
as of 12/11/2026- Market cap
- $20.98B
- Shares out
- 133.94M
- P/E (trailing)
- 7.92
- P/E (forward)
- 15.24
- EPS (trailing)
- 19.78
- Dividend yield
- 0.00%
- Beta
- 0.44
- Profit margin
- 68.88%
- P/B
- 5.82
- Return on equity
- 73.51%
SEC financial statements
63 quarterly and 18 annual periods through 30/09/2026.
Details
- Ticker
- ALNY
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
5 filers · 1 on watchlist · 4 buys · 4 sells · ?: 3 · D: 4 · R: 1
- 11/08/2026Cory A BookerSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/05/2025Jefferson ShreveSellAlnylam Pharmaceuticals, Inc. - Common Stock$15,001–$50,000
- 29/01/2024Josh GottheimerWSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/01/2024Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2023Josh GottheimerWSellAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 06/03/2023Daniel GoldmanBuyAlnylam Pharmaceuticals, Inc.$15,001–$50,000
- 28/09/2022Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 13/10/2016Richard L. HannaBuyAlnylam Pharmaceuticals, Inc. (ALNY) FILINg STATUS: New SUbHoLDINg oF: RHIRA$100,001–$250,000